Comorbid conditions in patients with erectile dysfunction in a community setting.
The objective of this study was to assess the prevalence of chronic comorbidities and the use of concomitant medications in men diagnosed with erectile dysfunction (ED) in a community setting, using a large integrated database. All patients who experienced an episode of ED during a two-month period were identified from the database. Comorbid conditions were determined through outpatient management claims and prescription claims for concomitant conditions were also assessed during the study period.
Gasper
S
S
Pfizer Inc, London.
Maytom
M
M
Okamoto
L
L
McLaughlin
T
T
D002908:Chronic Disease / Q000453:epidemiology*; D015897:Comorbidity; D003628:Database Management Systems; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000453:epidemiology; D017050:Episode of Care; D007172:Erectile Dysfunction / Q000453:epidemiology*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000453:epidemiology; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy / Q000453:epidemiology; D017202:Myocardial Ischemia / Q000188:drug therapy / Q000453:epidemiology; D015995:Prevalence; D011470:Prostatic Hyperplasia / Q000188:drug therapy / Q000453:epidemiology; D012307:Risk Factors; D014481:United States / Q000453:epidemiology